Assertio Holdings Acquired by Zydus Worldwide DMCC | Healthcare M&A Deal

Zydus Worldwide DMCC has completed the acquisition of Assertio Holdings, a pharmaceuticals business in Illinois, for $23.50 per share. Assertio Holdings is a healthcare-focused pharmaceutical company with operations tied to IL acquisitions, supporting Zydus Worldwide DMCC acquisitions in the pharmaceuticals sector. The going private acquisition structure supports a strategic acquisition by consolidating ownership of Assertio Holdings acquisition targets under Zydus control. The healthcare M&A deal is categorized as a strategic acquisition and going private acquisition, with the tender offer led by Zara Merger Sub Inc. and an announced over $100M deal size.